The Board of Directors of Guizhou Sanli Pharmaceutical Co.,Ltd has authorized a buyback plan on November 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 CNY | +2.97% | +2.19% | -13.67% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.67% | 920M | |
+29.98% | 682B | |
+32.16% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.45% | 240B | |
+9.47% | 209B | |
-9.00% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Guizhou Sanli Pharmaceutical Co.,Ltd authorizes a Buyback Plan.